Literature DB >> 8852961

Serological follow-up of human brucellosis by measuring IgG antibodies to lipopolysaccharide and cytoplasmic proteins of Brucella species.

P C Baldi1, S E Miguel, C A Fossati, J C Wallach.   

Abstract

A serological 2-year follow-up of 35 patients who had brucellosis with different clinical outcomes was performed. Patients were followed up by standard tube agglutination (STA) and 2-mercaptoethanol STA (2ME-STA) tests and by two enzyme-linked immunosorbent assays (ELISAs) to independently measure values of serum IgG to either lipopolysaccharide (LPS) or cytoplasmic proteins of Brucella. Whereas STA and 2ME-STA tests revealed characteristic antibody profiles for patients who recovered (group I), this was not the case for patients with persistent illness (group II) or patients with relapses (group III). On the other hand, titers measured by the 2ME-STA test were low or negative in 10 patients who had positive blood cultures. Levels of IgG antibodies to LPS and proteins in each group of patients exhibited characteristic changes. For group I, however, antibodies to proteins were better predictors of recovery, since titers reached negative values for five patients. Levels of IgG antibodies to LPS and proteins were persistently high in group II patients, and peaks in these antibody levels corresponded with relapses in group III patients. The determination of values of IgG antibodies to proteins by ELISA appears useful for the serological follow-up of patients with brucellosis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8852961     DOI: 10.1093/clinids/22.3.446

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  11 in total

1.  Effect of early antibiotic treatment on the antibody response to cytoplasmic proteins of Brucella melitensis in mice.

Authors:  R A Bowden; G C Racaro; P C Baldi
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

2.  Multiple abscesses in brucellosis with Wright's test negativity.

Authors:  Luca Dutto; Fulvio Pomero; Attilio Allione
Journal:  BMJ Case Rep       Date:  2009-02-27

3.  Detection of antibodies to Brucella cytoplasmic proteins in the cerebrospinal fluid of patients with neurobrucellosis.

Authors:  P C Baldi; G F Araj; G C Racaro; J C Wallach; C A Fossati
Journal:  Clin Diagn Lab Immunol       Date:  1999-09

Review 4.  Recognition and optimum treatment of brucellosis.

Authors:  J Solera; E Martínez-Alfaro; A Espinosa
Journal:  Drugs       Date:  1997-02       Impact factor: 9.546

5.  Diagnostic usefulness of antibodies against ribosome recycling factor from Brucella melitensis in human or canine brucellosis.

Authors:  Juliana Cassataro; M Victoria Delpino; Carlos A Velikovsky; Laura Bruno; Carlos A Fossati; Pablo C Baldi
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

6.  A sporadic outbreak of human brucellosis in Korea.

Authors:  Mi-Yeoun Park; Chang-Seop Lee; Young-Sil Choi; Seoung-Ju Park; Joo-Sun Lee; Heung-Bum Lee
Journal:  J Korean Med Sci       Date:  2005-12       Impact factor: 2.153

7.  Large scale immune profiling of infected humans and goats reveals differential recognition of Brucella melitensis antigens.

Authors:  Li Liang; Diana Leng; Chad Burk; Rie Nakajima-Sasaki; Matthew A Kayala; Vidya L Atluri; Jozelyn Pablo; Berkay Unal; Thomas A Ficht; Eduardo Gotuzzo; Mayuko Saito; W John W Morrow; Xiaowu Liang; Pierre Baldi; Robert H Gilman; Joseph M Vinetz; Renée M Tsolis; Philip L Felgner
Journal:  PLoS Negl Trop Dis       Date:  2010-05-04

8.  Occurrence and potential diagnostic applications of serological cross-reactivities between Brucella and other alpha-proteobacteria.

Authors:  M Victoria Delpino; Carlos A Fossati; Pablo C Baldi
Journal:  Clin Diagn Lab Immunol       Date:  2004-09

Review 9.  What have we learned from brucellosis in the mouse model?

Authors:  María-Jesús Grilló; José María Blasco; Jean Pierre Gorvel; Ignacio Moriyón; Edgardo Moreno
Journal:  Vet Res       Date:  2012-04-13       Impact factor: 3.683

10.  Human infection with M- strain of Brucella canis.

Authors:  Jorge C Wallach; Guillermo H Giambartolomei; Pablo C Baldi; Carlos A Fossati
Journal:  Emerg Infect Dis       Date:  2004-01       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.